Advance your academic career, collaborate globally, and expand your network— join now !

Massimiliano Calabrese

Prof. Massimiliano Calabrese

Department of Neuroscience Biomedicine and Movement, University of Verona

Share Link

Share

Information

Massimiliano Calabrese is Professor of Neurology at University of Verona. He leads the Regional Multiple Sclerosis Center of University of Verona and the International Centre for Advance Research in Multiple Sclerosis (ICARE-MS). Following medical degree and training in neurology at Padova University, he worked continuously in the Multiple Sclerosis Centre of Padova until 2013 when he moved to Verona University. From July 2004 to June 2005 he frequented an international stage in the Neuroimmunology Branch of National Institute of Health in Bethesda, MD, working on new MRI technology to visualize cortical grey matter pathology in Multiple Sclerosis. Since 2005 his clinical research activity has been focused on neurodegeneration and neuroprotection in Multiple Sclerosis, with the ultimate aim of predicting and of slowing down the accumulation and progression of irreversible disability. His work on grey matter inflammation and neurodegeneration in Multiple Sclerosis has earned more than 100 highly cited publications in international peer reviewed journals and several international awards.

Research Keywords & Expertise

Biomarkers
Immunology
MRI
Multiple Sclerosis
Demyelination

Short Biography

Massimiliano Calabrese is Professor of Neurology at University of Verona. He leads the Regional Multiple Sclerosis Center of University of Verona and the International Centre for Advance Research in Multiple Sclerosis (ICARE-MS). Following medical degree and training in neurology at Padova University, he worked continuously in the Multiple Sclerosis Centre of Padova until 2013 when he moved to Verona University. From July 2004 to June 2005 he frequented an international stage in the Neuroimmunology Branch of National Institute of Health in Bethesda, MD, working on new MRI technology to visualize cortical grey matter pathology in Multiple Sclerosis. Since 2005 his clinical research activity has been focused on neurodegeneration and neuroprotection in Multiple Sclerosis, with the ultimate aim of predicting and of slowing down the accumulation and progression of irreversible disability. His work on grey matter inflammation and neurodegeneration in Multiple Sclerosis has earned more than 100 highly cited publications in international peer reviewed journals and several international awards.